Literature DB >> 31930016

SABR-COMET: a new paradigm of care lights up the twilight of metastatic disease.

Paolo Sogono1, David L Ball1,2, Shankar Siva1,2.   

Abstract

Entities:  

Year:  2019        PMID: 31930016      PMCID: PMC6944625          DOI: 10.21037/atm.2019.10.96

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  2 in total

Review 1.  Radiotherapy in Oligometastatic, Oligorecurrent and Oligoprogressive Prostate Cancer: A Mini-Review.

Authors:  Alexander Yaney; Andrew Stevens; Paul Monk; Douglas Martin; Dayssy A Diaz; Shang-Jui Wang
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

2.  Evaluation of Patient-Reported Outcome Differences by Radiotherapy Techniques for Bone Metastases in A Population-Based Healthcare System.

Authors:  Robert A Olson; Vincent LaPointe; Alex Benny; Matthew Chan; Shilo Lefresne; Michael McKenzie
Journal:  Curr Oncol       Date:  2022-03-18       Impact factor: 3.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.